Ignite Creation Date:
2024-05-06 @ 2:15 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04265872
Status:
RECRUITING
Last Update Posted:
2023-11-30
First Post:
2020-01-23
Brief Title:
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Sponsor:
Baylor Research Institute
Organization:
Baylor Research Institute
Organization Data
Organization:
Baylor Research Institute
Class:
OTHER
Study ID:
020-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baylor Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None